• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Genocea Biosciences Inc.

    6/8/22 12:15:09 AM ET
    $GNCA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GNCA alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: June 7, 2022
    Accession Number: 0001457612-22-000077
    Submission Type: POS AM
    CIK: 0001457612
    Company Name: GENOCEA BIOSCIENCES, INC.
    File Number: 333-203981
    Get the next $GNCA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GNCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GNCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Duvall Diantha sold $81 worth of shares (1,355 units at $0.06), decreasing direct ownership by 2% to 75,388 units to satisfy tax liability

      4 - GENOCEA BIOSCIENCES, INC. (0001457612) (Issuer)

      6/3/22 4:13:21 PM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: Flechtner Jessica Baker sold $95 worth of shares (1,578 units at $0.06), decreasing direct ownership by 2% to 89,027 units (withholding obligation)

      4 - GENOCEA BIOSCIENCES, INC. (0001457612) (Issuer)

      6/3/22 4:12:24 PM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: Clark William D sold $241 worth of shares (4,023 units at $0.06), decreasing direct ownership by 1% to 304,377 units to satisfy withholding tax

      4 - GENOCEA BIOSCIENCES, INC. (0001457612) (Issuer)

      6/3/22 4:11:27 PM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GNCA
    SEC Filings

    See more
    • SEC Form 15-12B filed by Genocea Biosciences Inc.

      15-12B - GENOCEA BIOSCIENCES, INC. (0001457612) (Filer)

      6/13/22 5:21:30 PM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Genocea Biosciences Inc.

      EFFECT - GENOCEA BIOSCIENCES, INC. (0001457612) (Filer)

      6/13/22 12:15:11 AM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Genocea Biosciences Inc.

      EFFECT - GENOCEA BIOSCIENCES, INC. (0001457612) (Filer)

      6/13/22 12:15:07 AM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GNCA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SVB Leerink reiterated coverage on Genocea Biosciences with a new price target

      SVB Leerink reiterated coverage of Genocea Biosciences with a rating of Outperform and set a new price target of $6.00 from $5.00 previously

      4/6/21 7:42:43 AM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Needham reiterated coverage on Genocea Biosciences with a new price target

      Needham reiterated coverage of Genocea Biosciences with a rating of Buy and set a new price target of $6.00 from $7.00 previously

      2/11/21 11:14:26 AM ET
      $GNCA
      Biotechnology: Pharmaceutical Preparations
      Health Care